Literature DB >> 9674756

The laboratory diagnosis of haemoglobinopathies.

.   

Abstract

The laboratory diagnosis of haemoglobinopathies, including the thalassaemias, is of growing importance, particularly because of an increasing requirement for antenatal diagnosis of significant disorders of globin chain synthesis. This guideline discusses the laboratory tests which are most useful in the diagnosis of haemoglobinopathies and describes their role in specific clinical circumstances. Of the newer technical methods, high-performance liquid chromatography (HPLC) is of considerable importance whereas isoelectric focusing (IEF) and immunoassay for variant haemoglobins have a more minor role. Specific recommendations have been formulated for testing in relation to genetic counselling and for neonatal diagnosis. Methods used in specialized laboratories for fetal diagnosis have been tabulated. Genetic counselling requires: (i) identification of haemoglobins S, C, D-Punjab, O-Arab, E, Lepore and H, and (ii) the detection of carriers of alpha(0) and beta thalassaemia. It is recommended that subjects of all ethnic groups be screened for beta-thalassaemia trait, all except Northern European Caucasians for variant haemoglobins, and selected ethnic groups for alpha(0)-thalassaemia trait. Testing for beta-thalassaemia trait should be carried out when the mean cellular haemoglobin (MCH) is < 27 pg and testing for alpha(0)-thalassaemia trait should be considered when the MCH is < 25 pg. Appropriate methods include HPLC or haemoglobin electrophoresis for identification of variant haemoglobins and HPLC or microcolumn chromatography for quantification of haemoglobin A2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674756     DOI: 10.1046/j.1365-2141.1998.00809.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Frequency and type of newly diagnosed haemoglobin variants in Northern Italy.

Authors:  Giuseppe Lippi; Martina Montagnana; Elisa Danese; Gian Luca Salvagno; Francesca Bellorio; Massimo Franchini; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2010-10       Impact factor: 3.443

2.  A stochastic model to evaluate options for antenatal genetic screening.

Authors:  Steve Gallivan; Mark Jit; Martin Utley
Journal:  Health Care Manag Sci       Date:  2006-05

3.  Haemoglobinopathies encountered at Khoula Hospital, Oman: A retrospective study.

Authors:  Gihan Adly; A Rajappa
Journal:  Sultan Qaboos Univ Med J       Date:  2008-03

4.  Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis.

Authors:  A Lasco; N Morabito; A Gaudio; A Crisafulli; A Meo; G Denuzzo; N Frisina
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

5.  Falling prevalence of beta-thalassaemia and eradication of malaria in the Maldives.

Authors:  Naila Firdous; Stephen Gibbons; Bernadette Modell
Journal:  J Community Genet       Date:  2011-06-17

6.  High performance liquid chromatography (HPLC) as a screening tool for classical Beta-thalassaemia trait in malaysia.

Authors:  E George; A R Jamal; F Khalid; K A Osman
Journal:  Malays J Med Sci       Date:  2001-07

7.  Sandwich ELISA for hemoglobin A2 quantification and identification of beta-thalassemia carriers.

Authors:  Surakit Kuntaruk; Thanusak Tatu; Tiemjan Keowkarnkah; Watchara Kasinrerk
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

8.  Application of diagnostic methods and molecular diagnosis of hemoglobin disorders in Khuzestan province of Iran.

Authors:  Rahim Fakher; Kaeikhaei Bijan; Akbari Mohammad Taghi
Journal:  Indian J Hum Genet       Date:  2007-01

9.  Distribution of alpha thalassaemia gene variants in diverse ethnic populations in malaysia: data from the institute for medical research.

Authors:  Rahimah Ahmad; Mohamed Saleem; Nisha Sabrina Aloysious; Punithawathy Yelumalai; Nurul Mohamed; Syahzuwan Hassan
Journal:  Int J Mol Sci       Date:  2013-09-10       Impact factor: 5.923

Review 10.  Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition.

Authors:  Vip Viprakasit; Paul Tyan; Sarayuth Rodmai; Ali T Taher
Journal:  Orphanet J Rare Dis       Date:  2014-09-30       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.